enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ticagrelor - Wikipedia

   en.wikipedia.org/wiki/Ticagrelor

   Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y 12 receptor. [7]

3. Vortioxetine - Wikipedia

   en.wikipedia.org/wiki/Vortioxetine

   Vortioxetine was previously sold under the brand name Brintellix in the United States, but in May 2016, the US Food and Drug Administration (FDA) approved a name change to Trintellix in order to avoid confusion with the blood-thinning medication Brilinta . [57] [58] Other brand names include Torvox, Vantaxa, Voxigain, and Trivoxetin.

4. Thienopyridine - Wikipedia

   en.wikipedia.org/wiki/Thienopyridine

   Ticagrelor (Brilinta) is often listed with thienopyridine inhibitors and has similar indications for use but is not a thienopyridine. It is a cyclo-pentyltriazolo-pyrimidine that is distinct from the mechanism of the thienopyridines in that it reversibly (rather than irreversibly) inhibits the P2Y 12 receptor.

5. BRILINTA (ticagrelor) Launches "Complete the Course" — a ...

   www.aol.com/news/2012-09-19-brilinta-ticagrelor...

   BRILINTA (ticagrelor) Launches "Complete the Course" — a Creative Education Program for Patients With ACS, Including "Access My BRILINTA" Support Service Focused on Continuity of Care National ...

6. FDA Is Set Decide the Fate of AstraZeneca's Heart Drug Brilinta

   www.aol.com/news/2010-12-15-fda-astrazeneca...

   More than a year after AstraZeneca (AZN) filed for approval of its potential blockbuster heart drug Brilinta, the Food and Drug Administration appears ready to make its decision on Thursday. The ...

7. Bentracimab - Wikipedia

   en.wikipedia.org/wiki/Bentracimab

   Bentracimab is a monoclonal antibody medication which has been shown in phase one and two clinical trials to function as a reversal agent for the anti–blood clotting drug ticagrelor (which acts as a P2Y 12 inhibitor and is sold under the brand name Brilinta among others). [2]

8. Medicare's $2,000 prescription drug cap expected to bring ...

   www.aol.com/medicare-2-000-prescription-drug...

   Starting Jan. 1, older adults on Medicare will spend no more than $2,000 a year on prescription drugs when a new price cap on out-of-pocket payments from the Inflation Reduction Act goes into effect.

9. AOL Mail

   mail.aol.com

   Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!